Treatment of Cognitive and Negative Symptoms in Schizophrenia With N-acetylcysteine

NCT02505477 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia
Cognitive Deficits
Schizophrenia; Negative Type

Interventions

DRUG: N-acetylcysteine
OTHER: Treatment as Usual

Sponsor

University of California, Los Angeles